Genelux Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GNLX Nasdaq 2830 www.genelux.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genelux Corporation

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer - Jun 30th, 2026 6:00 am
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - May 7th, 2026 2:15 pm
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - Mar 19th, 2026 2:15 pm
Genelux Corporation to Participate in Upcoming Conferences - Feb 18th, 2026 6:00 am
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - Jan 12th, 2026 2:00 pm
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - Jan 8th, 2026 7:13 am
Genelux Corporation Announces Proposed Public Offering of Common Stock - Jan 7th, 2026 2:01 pm
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials - Jan 5th, 2026 6:00 am
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - Jan 2nd, 2026 6:00 am
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Nov 26th, 2025 6:00 am
Institutions along with retail investors who hold considerable shares inGenelux Corporation (NASDAQ:GNLX) come under pressure; lose 16% of holdings value - Nov 20th, 2025 3:35 am
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - Nov 5th, 2025 2:20 pm
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Oct 5th, 2025 7:22 am
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference - Sep 2nd, 2025 2:01 pm
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - Aug 7th, 2025 2:20 pm
3 Promising Penny Stocks With Market Caps Under $200M - Jul 15th, 2025 12:09 pm
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - Jul 7th, 2025 5:00 am